SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
SPRY
Price
$17.99
Change
+$0.19 (+1.07%)
Updated
Aug 6, 04:54 PM (EDT)
Capitalization
1.75B
7 days until earnings call
Interact to see
Advertisement

SLXN vs SPRY

Header iconSLXN vs SPRY Comparison
Open Charts SLXN vs SPRYBanner chart's image
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
ARS Pharmaceuticals
Price$17.99
Change+$0.19 (+1.07%)
Volume$2.34K
Capitalization1.75B
SLXN vs SPRY Comparison Chart in %
Loading...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLXN vs. SPRY commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a StrongBuy and SPRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (SLXN: $8.86 vs. SPRY: $17.80)
Brand notoriety: SLXN and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 38% vs. SPRY: 71%
Market capitalization -- SLXN: $5.13M vs. SPRY: $1.75B
SLXN [@Biotechnology] is valued at $5.13M. SPRY’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • SLXN’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both SLXN and SPRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • SLXN’s TA Score: 4 bullish, 5 bearish.
  • SPRY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than SLXN.

Price Growth

SLXN (@Biotechnology) experienced а -28.61% price change this week, while SPRY (@Biotechnology) price change was +0.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Reported Earning Dates

SPRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.75B) has a higher market cap than SLXN($5.13M). SPRY YTD gains are higher at: 68.720 vs. SLXN (-70.614). SLXN has higher annual earnings (EBITDA): -16.96M vs. SPRY (-27.07M). SPRY has less debt than SLXN: SPRY (73K) vs SLXN (3.48M). SPRY has higher revenues than SLXN: SPRY (97.1M) vs SLXN (0).
SLXNSPRYSLXN / SPRY
Capitalization5.13M1.75B0%
EBITDA-16.96M-27.07M63%
Gain YTD-70.61468.720-103%
P/E RatioN/A151.25-
Revenue097.1M-
Total CashN/A276M-
Total Debt3.48M73K4,770%
TECHNICAL ANALYSIS
Technical Analysis
SLXNSPRY
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 7 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
8%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
20%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
51%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFG2.940.14
+5.00%
Uni-Fuels Holdings Ltd
AMN17.490.06
+0.34%
AMN Healthcare Services
AMBO2.85N/A
-0.11%
Ambow Education Holding Ltd
AMCX5.98-0.03
-0.50%
AMC Networks
PATH11.22-0.12
-1.06%
UiPath

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+2.42%
LPCN - SPRY
63%
Loosely correlated
-1.60%
XOMA - SPRY
37%
Loosely correlated
+4.37%
ANAB - SPRY
35%
Loosely correlated
-2.23%
RCUS - SPRY
35%
Loosely correlated
+3.47%
KROS - SPRY
34%
Loosely correlated
-1.57%
More